Avalide
Pricing Report NDC 0087-2775-32

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Avalide (NDC 0087-2775-32) is $3.79899 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 21, 2013.

As a provided by Bristol-myers Squibb Company, this medication is distributed in a 90 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$3.79899
Per EA

Effective Date
Nov 21, 2013
Data Status
As of Nov 28, 2013
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 TABLET in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.32635 (Effective: Nov 21, 2013)
Pricing Methodology Explanation
The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.

Historical Pricing Trends & Acquisition Cost Benchmarks

The current wholesale price for (NDC ) is based on the most recent federal survey data. As this is a newer entry or has a stable pricing model, the chart below reflects the current established benchmark of $3.79899 per EA.

Historical Note: This product currently has limited pricing history. Trends will be available as more monthly survey data is collected by CMS.
Date Unit Price Unit Source Method Rate
Nov 21, 2013 $3.79899 EAC/I - Chain or Independent PharmacyCode 3B - Brand

Pricing Methodology Legend

  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026